Narrative review explores Veillonella's dynamic role in oral squamous cell carcinoma
Oral bacteria shift early in cancer and vanish as tumors grow
This narrative review examines the role of Veillonella species in oral squamous cell carcinoma (OSCC). The authors report a dynamic, stage-d…
A specific mouth bacteria appears early in cancer development but disappears as tumors grow larger, suggesting it helps start the problem ra…
Meta-analysis finds frozen section reliable for tumor-free margins in OSCC
Surgeons rely on frozen sections to ensure clean cuts for oral cancer patients
This systematic review and meta-analysis of 19 studies (9 with complete data) assessed frozen section analysis for detecting tumor-free marg…
A new review confirms that frozen section analysis is a highly reliable way for surgeons to check if oral cancer has been fully removed duri…
Narrative review discusses targeting ferroptosis and cuproptosis in oral squamous cell carcinoma
New ideas target cell death pathways for oral cancer
This narrative review explores the potential of targeting ferroptosis and cuproptosis in patients with oral squamous cell carcinoma.
A review explores fresh ways to fight oral cancer by targeting specific cell death pathways. This approach offers new hope for patients with…
Iron and oxidative stress biomarkers linked to oral cancer recurrence after surgery
Iron levels and oxidative stress linked to cancer return in oral squamous cell carcinoma patients
This retrospective cohort study of 240 patients with oral squamous cell carcinoma who underwent radical surgery found that 36.7% experienced…
Among 240 oral cancer patients, high iron and oxidative stress markers were more common in those whose cancer came back after surgery.
Personalized swallowing rehab improves outcomes after oral cancer surgery
New Swallowing Therapy Helps Oral Cancer Patients Eat and Speak More Easily
This randomized controlled trial in 300 patients with oral squamous cell carcinoma found that a personalized swallowing rehabilitation progr…
Personalized swallowing therapy helps oral cancer patients recover faster, eat more naturally, and avoid dangerous complications like pneumo…
High NSUN3 expression linked to poor survival in oral squamous cell carcinoma
High NSUN3 protein makes oral cancer spread faster
This cohort study of 60 oral squamous cell carcinoma patients found that upregulated NSUN3 expression is an independent risk factor for poor…
Imagine waking up with a sore in your mouth that won't heal.
Review links oral microbiome dysbiosis to malignant transformation in oral lichen planus
Bacteria That Turn Harmful Mouth Sores Into Cancer
This narrative review synthesizes evidence regarding oral microbiome dysbiosis as a potential driver of malignant transformation in oral lic…
Changing the bad bacteria in your mouth could stop a painful sore from becoming cancer.
Classification framework shows 79% to 98% performance for oral squamous cell carcinoma on histopathological images
AI Learns to Ignore Stains to Spot Mouth Cancer
A computer-aided classification study evaluated a framework combining staining-bias suppression and structured multiple-instance aggregation…
New AI technology learns to ignore stain colors, helping doctors spot mouth cancer more accurately even when lab dyes vary.
Systematic review finds serum biomarkers show variable diagnostic accuracy for oral cancer detection
Blood Tests Could Spot Oral Cancer Sooner
A systematic review and meta-analysis of 3,309 subjects (2,069 with oral squamous cell carcinoma, 1,240 controls) examined multiple serum bi…
New blood tests using specific proteins could detect oral cancer before a visible lump forms, potentially saving lives through earlier diagn…
Research across Head and Neck Cancer
Related studies from across the Head and Neck Cancer family.
Cetuximab-based regimens achieve 47% objective response rate in HNSCC after immune checkpoint inhibitor failure
Cetuximab shows activity for head and neck cancer patients
This meta-analysis evaluates cetuximab-based regimens for patients with recurrent or metastatic head and neck squamous cell carcinoma follow…
New data shows cetuximab-based treatments provide meaningful results for head and neck cancer patients after other treatments fail.
Immune cell-based therapy shows no significant benefits for tumor response or survival in HNSCC trials
Immune cell therapy shows limited promise for head and neck cancer
This meta-analysis of 30 trials involving 953 patients evaluated immune cell-based therapy (ICT) for head and neck squamous cell carcinoma. …
New data on immune cell-based therapies for head and neck cancer shows mixed results and a need for more rigorous testing.
Perioperative and postoperative immunotherapy timing determines clinical outcomes in locally advanced head and neck squamous cell carcinoma
Timing of immunotherapy affects outcomes for head and neck cancer
This narrative review examines the impact of immunotherapy sequencing on patients with locally advanced head and neck squamous cell carcinom…
The timing of immunotherapy treatment significantly changes how well it controls local and distant spread in head and neck cancer.
HPV16 constitutes 92.5% of single infections in oropharyngeal squamous cell carcinoma cases
HPV16 Remains the Most Common Type in Throat Cancer
This meta-analysis of 183 studies involving 17,443 patients identifies HPV16 as the predominant genotype in oropharyngeal squamous cell carc…
A large global study of over 17,000 cases shows that HPV16 is the primary driver of most HPV-related throat cancers.
ALC decline greater than 0.74x10^9/L independently predicts poorer OS and PFS in LA-HNSCC
Lymphocyte Drop During Radiation Tied to Worse Head and Neck Cancer Outcomes
This post-hoc analysis of a phase III trial involved 222 patients with locally advanced head and neck squamous cell carcinoma. The study fou…
A large drop in lymphocytes during radiation for head and neck cancer is linked to poorer survival. This finding may help personalize treatm…
Small bowel metastasis from esophageal squamous cell carcinoma shows male predominance and 6-month median survival
Small bowel spread from esophageal cancer has a short survival window
This systematic review of 23 patients with small bowel metastasis from esophageal squamous cell carcinoma found a strong male predominance (…
Patients with esophageal cancer that spreads to the small bowel often face a short survival window of about 6 months after diagnosis.
Genomic instability markers show associations with malignant transformation in oral leukoplakias and proliferative verrucous leukaplakias
Genomic markers show links to cancer in oral leukoplakia
This systematic review of 34 observational studies analyzed genomic instability markers in 3,237 patients with oral leukakias and proliferat…
New research identifies specific DNA markers that may help predict when oral leukoplakia turns into cancer.
PD-1/PD-L1 inhibitors provide superior overall survival compared to chemotherapy or cetuximab in platinum-refractory HNSCC
Newer drugs show better survival for advanced head and neck cancer
This meta-analysis of 5 RCTs involving 1,700 patients found that PD-1/PD-L1 inhibitors resulted in superior overall survival (HR: 0.80) comp…
A review of clinical trials shows that certain immunotherapy drugs offer better survival rates and fewer severe side effects than traditiona…
Toripalimab plus paclitaxel and cisplatin improves overall survival in advanced esophageal squamous-cell carcinoma
Trial shows toripalimab improves survival for advanced esophageal cancer
This Phase 3 randomized controlled trial of 514 treatment-naïve patients with advanced esophageal squamous-cell carcinoma found that toripal…
A new combination therapy involving toripalimab and chemotherapy significantly extended survival for patients with advanced esophageal squam…
TORS yields oncologic outcomes comparable to radiotherapy in early-stage oropharyngeal cancer
Robotic surgery shows promise as an alternative to radiation therapy
This systematic review of 51 clinical trials found that transoral robotic surgery (TORS) achieves oncologic outcomes comparable to radiother…
Robotic surgery may offer a way to reduce treatment intensity for some patients with throat cancer while maintaining survival rates.
Molecular drivers including DNA damage response and epigenetics contribute to treatment resistance in HPV-positive OPSCC
Understanding the Molecular Causes of Treatment Resistance in Throat Cancer
This systematic review examines the molecular architecture of treatment resistance in patients with HPV-positive oropharyngeal squamous cell…
Doctors are looking into why some throat cancers do not respond to standard treatments like radiation and chemotherapy.
Postoperative radiotherapy improves survival and reduces recurrence in resected ESCC
Radiotherapy After Surgery Improves Survival for Esophageal Squamous Cell Carcinoma
This meta-analysis of 11,385 patients with radically resected esophageal squamous cell carcinoma found that postoperative radiotherapy (PORT…
Adding radiation after surgery can improve survival rates and reduce local cancer recurrence for patients with esophageal squamous cell carc…
Questions about Oral Squamous Cell Carcinoma
Are there new treatments that target cell death to help oral squamous cell carcinoma?
Yes, new treatments targeting cell death pathways like ferroptosis, cuproptosis, and autophagy are being studied for oral squamous cell carcinoma, with some showing promise in early research.
Full answer →Can bacteria in my mouth change as my oral squamous cell carcinoma gets worse?
Yes, research shows that the oral microbiome, including bacteria like Veillonella, shifts as OSCC progresses, with different patterns in early vs. advanced stages.
Full answer →Does a specific blood test score predict my survival time after oral squamous cell carcinoma?
Yes, blood test scores like COP-MPV, mGPS, NLR, and PLR are linked to survival in OSCC, but they are not precise enough to predict individual survival time.
Full answer →